Overcoming constraints in Cell & Gene Therapy Facilities

Scalability, Sustainability and Cost of Goods

Andy Rayner, Pharma Sector Director and Chief Technology Officer, PM Group, will be presenting Cell and Gene Therapy: Overcoming Constraints in Scalability, Sustainability and Cost of Goods in Track C on 22nd August 2019, the first day of the conference.

The talk will appeal to a variety of industry practitioners including process engineers, facilities engineers, and architects, quality assurance, and pogistics professionals. Andy will cover:

• Logistics challenges
• Segregation principles
• Energy efficient and sustainable designs
• Modular design solutions
• Future factory solutions

About Andy Rayner

Andy is PM Group’s Executive Director for pharma and Chief Technology Officer. He has been with PM Group since 1989 and has over 30 years’ experience working with leading global pharma companies on projects all over the world. He is a leading international expert in the design of pharmaceutical manufacturing facilities. He is a Chemical Engineer and a Fellow of IChemE and also holds a Masters Degree in Executive Leadership.

Learn more about our work in Cell & Gene Therapy:

• CellVec - a gene therapy contract development and manufacturing organisation (CDMO)
• Robotics in Cell Therapy Manufacturing – Cleanroom Technology Magazine
• Modular Design including Cell Gene Therapy – BioPhorum Whitpaper
• Innovations in cell and gene therapy - ISPE Boston